Bausch Health Companies Price on October 1, 2021

071734AD9   40.92  12.00  22.68%   
If you're considering investing in Bausch Bond, it is important to understand the factors that can impact its price. As of today, the current price of Bausch stands at 40.92, as last reported on the 18th of April 2024, with the highest price reaching 40.92 and the lowest price hitting 40.92 during the day. Bausch Health Companies secures Sharpe Ratio (or Efficiency) of -0.0149, which signifies that the bond had a -0.0149% return per unit of risk over the last 3 months. Bausch Health Companies exposes twenty-eight different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Bausch's Downside Deviation of 5.82, risk adjusted performance of 0.0111, and Mean Deviation of 2.78 to double-check the risk estimate we provide.
  
Bausch Bond price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0149

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns071734AD9

Estimated Market Risk

 9.5
  actual daily
83
83% of assets are less volatile

Expected Return

 -0.14
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.01
  actual daily
0
Most of other assets perform better
Based on monthly moving average Bausch is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bausch by adding Bausch to a well-diversified portfolio.

Bausch Valuation on October 1, 2021

It is possible to determine the worth of Bausch on a given historical date. On October 1, 2021 Bausch was worth 89.29 at the beginning of the trading date compared to the closed value of 89.29. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Bausch bond. Still, in general, we apply an absolute valuation method to find Bausch's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Bausch where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Bausch's related companies.
 Open High Low Close Volume
04/04/2022
  89.29    89.29    89.29    89.29    400,000  
  89.46    89.46    89.46    89.46    500,000  
Backtest Bausch  |  Bausch History  |  Bausch Valuation Next  
Open Value
89.29
89.29
Closing Value
117.80
Upside

Bausch Trading Date Momentum on October 1, 2021

The event impact on price volatility cannot be determined at this time. Please check this event after some time to allow current data to be analyzed.

About Bausch Bond history

Bausch investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Bausch is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Bausch Health Companies will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Bausch stock prices may prove useful in developing a viable investing in Bausch
Bausch Health Companies Inc. is a specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. It operates in five business segments U.S. Neurology and Other, U.S. Dermatology, Canada and Australia, Branded Generics - Europe and Branded Generics -Latin America. On December 12, 2011, it acquired assets of the Ortho Dermatologics division of Janssen Pharmaceuticals, Inc. . On December 16, 2011, it acquired the dermatology business, Dermik, of Sanofi. On December 21, 2011, it acquired iNova, from Archer Capital, Ironbridge Capital and other minority management shareholders. On February 1, 2012, it acquired Probiotica Laboratorios Ltda. On February 3, 2012, it divested 1 percent clindamycin and 5 percent benzoyl peroxide gel , and 5 percent fluorouracil cream, . On March 12, 2012, it acquired a 19.9 percent interest in Pele Nova Biotecnologia S.A. In April 2012, it acquired Pedinol Pharmacal, Inc.

Bausch Bond Technical Analysis

Bausch technical bond analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, bond market cycles, or different charting patterns.
A focus of Bausch technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Bausch trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Bausch Period Price Range

Low
April 4, 2022
0.00  0.00%
High

 89.29 

     

 89.29 

Bausch April 18, 2024 Market Strength

Market strength indicators help investors to evaluate how Bausch bond reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Bausch shares will generate the highest return on investment. By undertsting and applying Bausch bond market strength indicators, traders can identify Bausch Health Companies entry and exit signals to maximize returns

Bausch Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Bausch's price direction in advance. Along with the technical and fundamental analysis of Bausch Bond historical price patterns, it is also worthwhile for investors to track various predictive indicators of Bausch to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Bausch Health Companies. Also, note that the market value of any corporate bond could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Please note, there is a significant difference between Bausch's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bausch is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bausch's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.